IceCure Medical Exhibits ProSense Cryoablation for Breast Cancer at EUSOBI 2026 in Maastricht  

*The breast cancer indication for the ProSense® System is currently under review by the FDA and has not yet received marketing clearance in the US. ProSense™ is cleared for the treatment of breast cancer in the EU and other select markets. Clinical indications vary by region, please contact us for additional details.  Explore ProSense™ Cryoablation […]